搜尋
Journey Medical Corp
DERM添加自選
6.550USD
-0.100-1.50%
交易中 （美東）報價延遲15分鐘
177.80M總市值
虧損本益比TTM
關於 Journey Medical Corp 公司
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
Journey Medical Corp 簡介
公司代碼DERM
公司名稱Journey Medical Corp
上市日期Nov 12, 2021
CEOMaraoui (Claude)
員工數量41
證券類型Ordinary Share
年結日Nov 12
公司地址9237 E Via De Ventura Blvd., Suite 105
城市SCOTTSDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編85258
電話14804346670
網址https://journeymedicalcorp.com/
公司代碼DERM
上市日期Nov 12, 2021
CEOMaraoui (Claude)
Journey Medical Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel, Corporate Secretary
Chief Operating Officer, General Counsel, Corporate Secretary
470.73K
+32.73%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
470.73K
+32.73%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Mr. Joseph Benesch, CPA
Mr. Joseph Benesch, CPA
Chief Financial Officer, Corporate Controller
Chief Financial Officer, Corporate Controller
187.57K
+46.27%
Mr. Joseph Benesch, CPA
Mr. Joseph Benesch, CPA
Chief Financial Officer, Corporate Controller
Chief Financial Officer, Corporate Controller
187.57K
+46.27%
Mr. Neil Herskowitz
Mr. Neil Herskowitz
Independent Director
Independent Director
141.44K
+35.35%
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Independent Director
Independent Director
141.44K
+35.35%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel, Corporate Secretary
Chief Operating Officer, General Counsel, Corporate Secretary
470.73K
+32.73%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
470.73K
+32.73%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
常見問題
Journey Medical Corp的前五大股東是誰？
Journey Medical Corp的前五大股東如下：Mr. Claude Maraoui
有多少機構持有Journey Medical Corp(DERM)的股份？
截至2026Q1，共有137家機構持有Journey Medical Corp的股份，合計持有的股份價值約為12.08M，占公司總股份的56.62% 。與2025Q4相比，機構持股有所增加，增幅為2740272.00。
哪個業務部門對Journey Medical Corp的收入貢獻最大？
在2026Q1，Qbrexa業務部門對Journey Medical Corp的收入貢獻最大，創收25.01M，占總收入的40.85% 。